PSMA PET/CT May Discriminate Clinically Significant Prostate Cancer for Biopsy
Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI.
Diagnosis & Disease Information
MRI-Guided Radiation Therapy Bests CT Guidance for Prostate Cancer
Benefits seen for genitourinary and gastrointestinal toxic effects
Higher Prostate Cancer Mortality Among Black Men Tied to Social Determinants of Health
Prostate cancer has one of the largest racial disparities in outcomes between Black and White patients, according to investigators.
On-Site Genetic Testing for Prostate Cancer Increases Patient Compliance
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7%
Per-Patient Costs of Metastatic Prostate Cancer Exceed $30,000
Increase in annual attributable costs observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017
Prostate Cancer ADT Increases Bone Fracture Risk
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
Genitourinary Cancer Incidence and Mortality Varies by Region, Race, and Sex
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Prostate Cancer Survival Slightly Lower With Active Surveillance
Data suggest that 125 men active surveillance would need to receive initial treatment to prevent 1 prostate cancer death at 10 years.
Prostate Cancer Consensus Conference Offers Guide to Clinical Dilemmas
An international panel weighed in on management controversies in intermediate- and high-risk and locally advanced prostate cancer.
AI Platform Promises Improved Prostate Cancer Management
A new product called iQuest has the potential to define the extent of cancer more accurately.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...